Rhythm Pharmaceuticals, Inc.

Rare neuroendocrine-disease biotech focused on precision MC4R agonists for genetically and hypothalamically driven obesity.

Back to company catalog

Rare neuroendocrine obesity · MC4R agonists · Commercial + Phase 3

Compare report options